Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Status Completed

Clinical Trial Summary

BACKGROUND Breast cancer-related lymphedema is a severe and life-long side-effect to breast cancer treatment. The condition increases the risk of infections and decreases health-related quality of life (HR-QOL) in patients. No prophylactic or curative treatment is currently available for this condition. CD4+-cells plays a critical role in the development of lymphedema. The cells facilitate inflammation and fibrosis formation in the subcutaneous tissue which inhibits lymphatic regeneration. Tacrolimus is an immunosuppressive and anti-inflammatory macrolide that targets the CD4+-cells. Tacrolimus as treatment of lymphedema has already shown promising results in animal studies. Tacrolimus has the potential to cure an otherwise uncurable and life-long side-effect of BC and will therefore benefit a large number of patients who suffers from BCRL. AIM To assess the effect of Tacrolimus treatment on breast cancer-related lymphedema METHOD Study design A pilot study with a planned inclusion of 20 patients with a 12 month follow-up period. The purpose of this study is to assess the effect of tacrolimus treatment on lymphedema and HR-QOL. Results are attained from objective measures and questionnaires. The patients will be seen at a consultation prior to the treatment start and then 3 times hereafter (at 3, 6 and 12 months) as follow up consultations where effect of treatment is evaluated. Primary endpoint: - Arm volume measured with water displacement test. Secondary endpoints: - Arm volume measured with measuring tape and calculated with volume of a cone formula - Patient-reported outcome measured through the Danish versions of , LYMPH-ICF, DASH and SF-36 questionnaires - Bioimpedance - Lymphangiography Primary- and secondary endpoint data will be collected at each of the 3 consultations (prior to treatment and 3 and 6 months after the treatment start). CLINICAL IMPACT This will be the first clinical pharmacological study on regarding treatment of lymphedema with Tacrolimus. This study will test the feasibility and efficacy of Tacrolimus ointment in a population of breast cancer patients who have developed lymphedema. The study may lead to a routine clinical implementation of tacrolimus ointment to patients diagnosed with Lymphedema. Regardless of the outcome, the study will benefit the patients and future research in the field of lymphedema.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04541290
Study type	Interventional
Source	Odense University Hospital
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	September 22, 2020
Completion date	January 6, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03300349` - Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.	N/A
Recruiting	`NCT05725265` - LLLT for BCRL: a Randomized, Placebo-controlled Study	N/A
Not yet recruiting	`NCT04272372` - Lymphedema Treatment Registry
Recruiting	`NCT05983380` - The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors	N/A
Not yet recruiting	`NCT04158193` - Acupuncture for Breast Cancer Related Lymphedema	N/A
Completed	`NCT04098783` - Health Belief Model Based Nursing Interventions on Lymphedema Prevention	N/A
Active, not recruiting	`NCT05441943` - Lymphaticovenous Anastomosis as Treatment for Lymphedema	N/A
Completed	`NCT04832386` - COMPRESSION GARMENTS in BREAST CANCER-RELATED LYMPHEDEMA
Recruiting	`NCT04787029` - Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study	N/A
Recruiting	`NCT06302361` - Lymphovenous Anastomosis for Breast Cancer Lymphedema	N/A
Completed	`NCT05595330` - Effect of Lymphedema Prevention Program Based on Theory of Knowledge-attitude-practice on Postoperative Breast Cancer Patients	N/A
Completed	`NCT03762044` - New Therapeutic Approach in Upper Limb Lymphedema Secondary to Breast Cancer: Activity-oriented Proprioceptive Antiedema Therapy (TAPA)	N/A
Completed	`NCT05660590` - Effect of Different Bandage Interface Pressures on Breast Cancer Related Lymphedema	N/A
Recruiting	`NCT04125953` - Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy	N/A
Completed	`NCT04766489` - Evaluation of the Treatment Response in Breast Cancer Related Lymphedema	N/A
Completed	`NCT04166279` - The Recovery of Reaching Movement in Breast Cancer Survivors: Two Different Rehabilitative Protocols in Comparison	N/A
Recruiting	`NCT05120180` - Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast Cancer	N/A
Completed	`NCT03051776` - Kinesio Taping Versus Compression Garments for Breast Cancer-Related Lymphedema	N/A
Active, not recruiting	`NCT04241341` - Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection	Phase 3
Completed	`NCT05119049` - Efficacy of Aquatic Physiotherapy in the Treatment of Upper Limb Lymphedema in Women With Breast Cancer.	N/A